A detailed history of Zacks Investment Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 6,209 shares of MEDP stock, worth $2.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,209
Previous 5,327 16.56%
Holding current value
$2.5 Million
Previous $1.63 Million 53.74%
% of portfolio
0.03%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $251,255 - $364,539
882 Added 16.56%
6,209 $2.51 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $59,382 - $81,609
-261 Reduced 4.67%
5,327 $1.63 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $404,083 - $486,444
-1,727 Reduced 23.61%
5,588 $1.35 Million
Q2 2023

Aug 15, 2023

BUY
$187.26 - $240.17 $158,234 - $202,943
845 Added 13.06%
7,315 $1.76 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $109,734 - $140,739
-586 Reduced 8.3%
6,470 $1.55 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $24,054 - $33,053
138 Added 1.99%
7,056 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $705,453 - $1.04 Million
4,609 Added 199.61%
6,918 $1.47 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $6,966 - $8,759
-48 Reduced 2.04%
2,309 $363,000
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $41,273 - $53,265
317 Added 15.54%
2,357 $353,000
Q1 2022

May 13, 2022

SELL
$138.87 - $214.31 $16,247 - $25,074
-117 Reduced 5.42%
2,040 $334,000
Q4 2021

Feb 15, 2022

BUY
$182.74 - $227.9 $394,170 - $491,580
2,157 New
2,157 $470,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.